Form 4: Immunome Inc. Chief Scientific Officer Higgins Exercises Options and Sells Shares

Immunome Inc.'s Chief Scientific Officer, Jack Higgins, exercised stock options and sold shares to cover the transaction.

Summary

• On August 15, 2024, Jack Higgins, Chief Scientific Officer of Immunome Inc., exercised options to acquire 19,524 shares of common stock at a price of $1.35 per share.
• Simultaneously, Higgins sold 3,524 shares of common stock at a weighted average price of $13.925 per share, with prices ranging from $13.800 to $14.020.
• On August 19, 2024, Higgins gifted 2,471 shares.
• Following these transactions, Higgins directly owns 13,529 shares of Immunome Inc. common stock and holds options for 179,040 shares.

Sentiment

Score: 5

Explanation: The document is a standard SEC filing detailing insider transactions, which is neutral in sentiment. It reflects routine financial activity.

Industry Context

This Form 4 filing is a routine disclosure of insider transactions, providing transparency into the trading activities of company executives. It's common for executives to exercise stock options and sell a portion of the shares to cover the cost of exercising the options and associated taxes.

Stakeholder Impact

• The sale of shares by a company officer could be perceived negatively by some investors, but it's a common practice to cover option exercise costs.
• The transactions have a minimal direct impact on employees, customers, suppliers, or creditors.

Key Dates